SCHEMBL20209836

SCHEMBL20209836

CCCCCCCCCc1cocn1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 1/20 0.47
PPARA Q07869 1/20 0.36
PTGS2 P35354 3/20 0.34
ESR1 P03372 2/20 0.34
ADRA2A P08913 2/20 0.34
ADORA3 P0DMS8 2/20 0.34
TACR2 P21452 2/20 0.34
SLC6A2 P23975 2/20 0.34
SLC6A4 P31645 2/20 0.34
SLC6A3 Q01959 2/20 0.34
KDM4E B2RXH2 2/20 0.34
ALDH1A1 P00352 2/20 0.34
HSD17B10 Q99714 2/20 0.34
LMNA P02545 1/20 0.34
SHBG P04278 1/20 0.34
TP53 P04637 1/20 0.34
CYP3A4 P08684 1/20 0.34
HSPD1 P10809 1/20 0.34
ADRB3 P13945 1/20 0.34
HTR2C P28335 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6664982 0.98 KCNH2 (0.44) KCNH2PPARAPTGS2CYP3A4CYP19A1
Hydrochloric Acid SCHEMBL3721911 0.96 KCNH2 (0.42) KCNH2PPARAPTGS2CYP3A4CYP19A1
SCHEMBL7073457 0.92
SCHEMBL5535572 0.80
SCHEMBL5541723 0.78
SCHEMBL27329523 0.72 KCNH2 (0.56) KCNH2PTGS2ESR1ADRA2AADORA3
SCHEMBL358519 0.70
SCHEMBL5436769 0.69 KCNH2 (0.52) KCNH2PTGS2ESR1ADRA2AADORA3
SCHEMBL1685607 0.68 KCNH2 (0.52) KCNH2PPARAPTGS2ESR1ADRA2A
Hydrochloric Acid SCHEMBL14744435 0.68 TDP1 (0.39)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111303386-A Lizodiazole copolymer photovoltaic material, preparation method and application 湖南文理学院 2020-06-19 CN claimed
CN-111303386-A Lizodiazole copolymer photovoltaic material, preparation method and application 湖南文理学院 2020-06-19 CN disclosed
US-10208068-B2 Macrocycles as factor XIa inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2019-02-19 US disclosed
US-20180148461-A1 NOVEL MACROCYCLES AS FACTOR XIA INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2018-05-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180148461-A1 NOVEL MACROCYCLES AS FACTOR XIA INHIBITORS TFPI, TFPI2, F12 KCNH2 1986/4885PPARA 4873/4885PTGS2 1584/4885
US-10208068-B2 Macrocycles as factor XIa inhibitors TFPI, TFPI2, F12 KCNH2 1883/4885PPARA 4860/4885PTGS2 1202/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.